Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
Jorge J CastilloThomas Guerrero-GarciaFrancesco BaldiniEmmanuelle TchernonogGuillaume CartronSlavisa NinkovicKate CwynarskiDaan DierickxThomas TousseynFrederick LansiganYevgeny LinnikRenzo MogollonJose-Tomás NavarroAdam J OlszewskiJohn L ReaganPasquale FedeleMichael GilbertsonGeorge GrigoriadisMichele BibasPublished in: British journal of haematology (2018)
Keyphrases